Trial Outcomes & Findings for Ambispective, Multicentre, Open-label Study Evaluating the Clinical Outcomes of Foot Surgery Using SERF Medical Devices (NCT NCT05672069)

NCT ID: NCT05672069

Last Updated: 2025-01-13

Results Overview

The information will be collected through AOFAS (American Orthopaedic Foot and Ankle Society) score (\>80 points) at 12 months. This score is assessed using a questionnaire measuring the patient's pain, function and alignment of the foot. This score range from 0 (worst score) to 100 (best score). The score is interpreted as follows : Between 90-100 points : excellent results Between 80-89 points : good results Between 60-79 points : fair results Less than 60 points : poor results This score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points.

Recruitment status

COMPLETED

Target enrollment

124 participants

Primary outcome timeframe

12 months

Results posted on

2025-01-13

Participant Flow

Participant milestones

Participant milestones
Measure
Total Cohort
The description will be carried out on the whole population really included
Overall Study
STARTED
124
Overall Study
COMPLETED
121
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Total Cohort
The description will be carried out on the whole population really included
Overall Study
Implant removal
1
Overall Study
Lost to Follow-up
2

Baseline Characteristics

Ambispective, Multicentre, Open-label Study Evaluating the Clinical Outcomes of Foot Surgery Using SERF Medical Devices

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Total Cohort
n=124 Participants
The description will be carried out on the whole population really included
Age, Continuous
58.20 years
STANDARD_DEVIATION 12.89 • n=5 Participants
Sex: Female, Male
Female
99 Participants
n=5 Participants
Sex: Female, Male
Male
25 Participants
n=5 Participants
Race/Ethnicity, Customized
French nationality
124 Participants
n=5 Participants
Operated foot side
Right
65 Number of foot
n=5 Participants
Operated foot side
Left
72 Number of foot
n=5 Participants
Foot position
Front of foot
123 Number of foot
n=5 Participants
Foot position
Middle of foot
6 Number of foot
n=5 Participants
Foot position
Front + Middle of foot
3 Number of foot
n=5 Participants
Foot position
Back of foot
5 Number of foot
n=5 Participants
Weight (kg)
66.72 Kg
STANDARD_DEVIATION 14.12 • n=5 Participants
Height of participant (cm)
165.85 cm
STANDARD_DEVIATION 7.23 • n=5 Participants

PRIMARY outcome

Timeframe: 12 months

The information will be collected through AOFAS (American Orthopaedic Foot and Ankle Society) score (\>80 points) at 12 months. This score is assessed using a questionnaire measuring the patient's pain, function and alignment of the foot. This score range from 0 (worst score) to 100 (best score). The score is interpreted as follows : Between 90-100 points : excellent results Between 80-89 points : good results Between 60-79 points : fair results Less than 60 points : poor results This score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points.

Outcome measures

Outcome measures
Measure
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
Reduction of the Patient's Pain and Restoration of Walking
Preoperatively
42.46 points
Standard Deviation 15.25
Reduction of the Patient's Pain and Restoration of Walking
12 months
88.44 points
Standard Deviation 13.50

SECONDARY outcome

Timeframe: 12 months

Determination of the Kaplan-Meier type survival curve, with any revision as the endpoint whatever the cause. At each inflection point, a revision surgery with removal or revision surgery with removal or change of a component of the implant under consideration All causes of revision are considered. Patients who have died or been lost to follow-up will be included in the analysis.

Outcome measures

Outcome measures
Measure
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
Survival Rate
89.3 percentage of implant survivorship

SECONDARY outcome

Timeframe: 12 months

The information will be collected through investigator's question : "on radiographic reading, is the foot bone consolidation satisfactory? : 4 answers are proposed: "total / partial / null / no information".

Outcome measures

Outcome measures
Measure
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
Foot Bone Consolidation
Total
124 Number of foot
Foot Bone Consolidation
Partial
2 Number of foot
Foot Bone Consolidation
No consolidation
1 Number of foot
Foot Bone Consolidation
Not determined
7 Number of foot

SECONDARY outcome

Timeframe: 12 months

The information will be collected through patient's question : "Considering your expectations, are you satisfied with your operation?" 4 answers are proposed: "I am completely satisfied with the results of my operation results of my operation / My condition has not improved as much as I had hoped, but I but I would be willing to have the same operation for the same result / The operation improved my condition, but I would not be prepared to have the same operation for the same result / My condition is the same or worse than before my operation than before my operation".

Outcome measures

Outcome measures
Measure
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
Patient Satisfaction
Very satisfied
103 Number of foot
Patient Satisfaction
Satisfied
20 Number of foot
Patient Satisfaction
Neither satisfied nor unsatisfied
6 Number of foot
Patient Satisfaction
Unsatisfied
5 Number of foot

SECONDARY outcome

Timeframe: Peroperative to 12 months

Type and occurrence of adverse events

Outcome measures

Outcome measures
Measure
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
Adverse Event
Discomfort
8 Number of foot
Adverse Event
Pain
3 Number of foot
Adverse Event
Pseudoarthrosis
2 Number of foot
Adverse Event
Screw protrusion
2 Number of foot
Adverse Event
Persistent pain (consolidation with screw protrusion)
1 Number of foot
Adverse Event
Post-operative neurological disorders
1 Number of foot
Adverse Event
Stiff joint (hallux positioning problem)
1 Number of foot
Adverse Event
Loss of correction
1 Number of foot
Adverse Event
Scar disunion (poor effectiveness of meching)
1 Number of foot
Adverse Event
Locking default between locking screws/plate
1 Number of foot

Adverse Events

Total Cohort

Serious events: 5 serious events
Other events: 16 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Total Cohort
n=121 participants at risk
The adverse event occurred in an implanted foot.
Surgical and medical procedures
Persistent pain (consolidation with screw protrusion)
0.83%
1/121 • 12 months
Surgical and medical procedures
Arthrodesis pseudarthrosis
0.83%
1/121 • 12 months
Nervous system disorders
Post-operative neurological disorders
0.83%
1/121 • 12 months
Surgical and medical procedures
Screw protrusion
0.83%
1/121 • 12 months
Surgical and medical procedures
Pseudarthrosis
0.83%
1/121 • 12 months

Other adverse events

Other adverse events
Measure
Total Cohort
n=121 participants at risk
The adverse event occurred in an implanted foot.
Injury, poisoning and procedural complications
Persistent / residual pain
2.5%
3/121 • 12 months
Surgical and medical procedures
Screws protrusion
0.83%
1/121 • 12 months
Injury, poisoning and procedural complications
Discomfort
6.6%
8/121 • 12 months
Surgical and medical procedures
Loss of correction
0.83%
1/121 • 12 months
Surgical and medical procedures
Scar disunion (poor effectiveness of meching)
0.83%
1/121 • 12 months
Surgical and medical procedures
Locking default between locking screws /plate
0.83%
1/121 • 12 months
Surgical and medical procedures
Stiff joint (hallux positioning problem)
0.83%
1/121 • 12 months

Additional Information

Sponsor

SERF

Phone: +33 4.72.05.60.10

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place